Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Infinity Announces the Date of Its Second Quarter 2013 Financial Results Conference Call and Webcast



  Infinity Announces the Date of Its Second Quarter 2013 Financial Results
  Conference Call and Webcast

Business Wire

CAMBRIDGE, Mass. -- August 1, 2013

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on
Thursday, August 8, 2013, at 8:30 a.m. ET. During the call, management will
review the company's second quarter 2013 financial results and provide an
update on Infinity's business.

A live webcast of the conference call can be accessed in the Investors/Media
section of Infinity's website at www.infi.com. To participate in the
conference call, please dial 1-877-316-5293 (domestic) and 1-631-291-4526
(international) five minutes prior to start time. The conference ID number is
23079300. An archived version of the webcast will be available on Infinity's
website for 30 days.

About Infinity Pharmaceuticals, Inc.

Infinity is an innovative biopharmaceutical company dedicated to discovering,
developing and delivering best-in-class medicines to people with
difficult-to-treat diseases. Infinity combines proven scientific expertise
with a passion for developing novel small molecule drugs that target emerging
disease pathways. Infinity’s programs focused on the inhibition of
phosphoinositide-3-kinase and heat shock protein 90 are evidence of its
innovative approach to drug discovery and development. For more information on
Infinity, please refer to the company’s website at www.infi.com.

Contact:

Infinity Pharmaceuticals, Inc.
Kate Murray, 617-453-1179
Kate.Murray@infi.com
http://www.infi.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement